2724. Community-acquired Pneumonia in Immunocompromised Patients: Predictors and Outcomes Associated with Empiric Broad-spectrum Antibiotic Treatment

BACKGROUND: Immunocompromised patients (ICP) are at higher risk of infection, but are often excluded from trials for community-acquired pneumonia (CAP). Due to limited data on CAP treatment in ICP, the IDSA/ATS CAP guideline omits recommendations for ICP. We aimed to assess predictors and outcomes a...

Descripción completa

Detalles Bibliográficos
Autores principales: Saravolatz, Louis, Gandhi, Tejal N, Vaughn, Valerie, Ratz, David, Horowitz, Jennifer K, Gupta, Ashwin, McLaughlin, Elizabeth, Weinmann, Allison J, Paje, David, Malani, Anurag, Dumkow, Lisa E, Flanders, Scott A, Petty, Lindsay A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678553/
http://dx.doi.org/10.1093/ofid/ofad500.2335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678553/
http://dx.doi.org/10.1093/ofid/ofad500.2335

Ejemplares similares